The effects of raloxifene treatment on oxidative status in brain tissues and learning process of ovariectomized rats

The effects of raloxifene treatment on oxidative status in brain tissues and learning process of ovariectomized rats

Background: The effects of estrogene on central nervous system are still controversial. Objective: We aimed to investigate the effects of raloxifene on the antioxidant enzyme [superoxide dismutase (SOD) and catalase (CAT)] activities and malondialdehyde (MDA) levels in brain homogenates of ovariecto...

Full description

Bibliographic Details
Main Authors:	Süreyya Osmanova, Ebru Sezer, Volkan Turan, Burak Zeybek, Mustafa Cosan Terek, Lutfiye Kanıt
Format:	Article
Language:	English
Published:	Shahid Sadoughi University of Medical Science, Yazd, Iran 2011-01-01
Series:	Iranian Journal of Reproductive Medicine
Subjects:	Oxidative stress Raloxifene Active avoidence task Cognitive process
Online Access:	http://www.ijrm.ir/library/upload/article/af_23339336)%2089-61-2.pdf

Similar Items

Raloxifene Ameliorates Glucosamine-Induced Insulin Resistance in Ovariectomized Rats
by: Chung-Hwan Chen, et al.
Published: (2021-08-01)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
by: Abdurrahman Yeter, et al.
Published: (2014-12-01)

Aktuelles: Frakturprävention: Raloxifen und Knochenqualität
by: Hasenöhrl N
Published: (2013-01-01)

The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)

Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells
by: Hsin-Hsueh Shen, et al.
Published: (2019-08-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Ekspresi Tartrate-Resistant Acid Phosphatase-5b pada Epifisis Tulang Femur Tikus Ovariektomi yang Mengkonsumsi Calcitriol dan Raloxifene (TARTRATE-RESISTANT ACID PHOSPHATASE-5b EXPRESSION OF EPIPHYSYS DISTALIS FEMUR OVARIECTOMIZED RATS CONSUMING CALCITRIO
by: Hartiningsih ., et al.
Published: (2016-03-01)

Endometrial hysteroscopic and histological evaluation in menopausal women in continuous use of raloxifene
by: Vanessa Maria Caetano Soares, et al.
Published: (2010-03-01)

Investigation of in vitro and in vivo effects of raloxifene on the pulmonary and systemic vascular circulations.
Published: (2005)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia
by: Mohammad-Reza Khodaie-Ardakani, et al.
Published: (2015-06-01)

The Pharmacokinetics of Raloxifene and Its Interaction with Apigenin in Rat
by: Ming Hu, et al.
Published: (2010-11-01)

Massive pulmonary embolism in rheumatoid patient treated with raloxifene: a case report
by: Hala M Haider
Published: (2014-01-01)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)

Determination of raloxifene hydrochloride in human urine by LC-MS-MS
by: K. Tharpa, et al.
Published: (2009-09-01)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)

Respon Sistem Homeostasis Kalsium Tikus Ovariektomi yang Mengkonsumsi Kombinasi Calcitriol dengan Raloxifene
by: Hartiningsih Hartiningsih, et al.
Published: (2017-02-01)

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
by: Yurie Norimatsu, et al.
Published: (2021-09-01)

The Effects of Zoledronate and Raloxifene Combination Therapy on Diseased Mouse Bone
by: Powell, Katherine M.
Published: (2019)

New treatment paradigm of combined raloxifene and conjugated estrogen for postmenopausal symptoms in VCD-ind
by: Marwa N. Emam, et al.
Published: (2017-08-01)

Raloxifene Protects Cisplatin-Induced Renal Injury in Mice via Inhibiting Oxidative Stress
by: An JH, et al.
Published: (2021-09-01)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
by: Victor G Vogel
Published: (2008-12-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

LC-UV method to assay raloxifene hydrochloride in rat plasma and its application to a pharmacokinetic study
by: Márcia Camponogara Fontana, et al.

Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects Implicating the HO-System
by: Denise Börzsei, et al.
Published: (2020-02-01)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
by: Fujiwara S, et al.
Published: (2014-11-01)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
by: Thomas W. Weickert, et al.
Published: (2017-10-01)

The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation.
by: Roxana Flores, et al.
Published: (2016-12-01)

Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
by: Xinhui Du, et al.
Published: (2021-01-01)

Development and Evaluation of Raloxifene-Hydrochloride-Loaded Supersaturatable SMEDDS Containing an Acidifier
by: Jong-Hwa Lee, et al.
Published: (2018-06-01)

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol
by: Bodyl A. Brand, et al.
Published: (2020-12-01)

Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene
by: Trdan Lušin Tina, et al.
Published: (2012-04-01)

Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement
by: Zaihua Wang, et al.
Published: (2018-06-01)

Immersion in Raloxifene does not significantly improve bone toughness or screw pull-out strength in multiple in vitro models
by: Michael R. Eby, et al.
Published: (2021-05-01)

Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): A systematic analysis
by: Ying Hui, et al.
Published: (2015-07-01)

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
by: Aditya Murthy, et al.
Published: (2020-05-01)

Induction of mitochondrial apoptotic pathway by raloxifene and estrogen in human endometrial stromal ThESC cell line
by: Ivana Nikolic, et al.
Published: (2016-05-01)

Porous Microparticles Containing Raloxifene Hydrochloride Tailored by Spray Freeze Drying for Solubility Enhancement
by: Seyyed Pouya Hadipour Moghaddam, et al.
Published: (2018-06-01)

Novel Biodegradable Polyesters. Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl Loaded Nanoparticles
by: Evangelos Karavas, et al.
Published: (2009-07-01)